These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8092828)

  • 1. Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution.
    Berger BJ; Fairlamb AH
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1298-302. PubMed ID: 8092828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism.
    Fairlamb AH; Carter NS; Cunningham M; Smith K
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):213-22. PubMed ID: 1501641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of dithiol ligands to in vitro and in vivo trypanocidal activities of dithiaarsanes and investigation of ligand exchange in an aqueous solution.
    Loiseau PM; Lubert P; Wolf JG
    Antimicrob Agents Chemother; 2000 Nov; 44(11):2954-61. PubMed ID: 11036006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin.
    Scott AG; Tait A; Turner CM
    Acta Trop; 1996 Feb; 60(4):251-62. PubMed ID: 8659324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic method for the separation and quantitative estimation of anti-parasitic melaminophenyl arsenical compounds.
    Berger BJ; Fairlamb AH
    Trans R Soc Trop Med Hyg; 1994; 88(3):357-9. PubMed ID: 7974690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations of the metabolites of the trypanocidal drug melarsoprol.
    Keiser J; Ericsson O; Burri C
    Clin Pharmacol Ther; 2000 May; 67(5):478-88. PubMed ID: 10824626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the trypanocidal drug melarsoprol and its conversion products in biological fluids with HPLC-ICPMS/ESMS.
    Raber G; Raber T; Raml R; Murko M; Magnes C; Francesconi KA
    Talanta; 2013 Nov; 116():876-81. PubMed ID: 24148488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The melaminophenyl arsenicals melarsoprol and melarsen oxide interfere with thiamine metabolism in the fission yeast Schizosaccharomyces pombe.
    Schweingruber ME
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3268-71. PubMed ID: 15328083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
    Scott AG; Tait A; Turner CM
    Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanothione is the primary target for arsenical drugs against African trypanosomes.
    Fairlamb AH; Henderson GB; Cerami A
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2607-11. PubMed ID: 2704738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1992; 86(3):257-8. PubMed ID: 1412647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
    Cunningham ML; Zvelebil MJ; Fairlamb AH
    Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the biotransformation of melarsoprol by electrochemistry coupled to complementary LC/ESI-MS and LC/ICP-MS analysis.
    Baumann A; Pfeifer T; Melles D; Karst U
    Anal Bioanal Chem; 2013 Jun; 405(15):5249-58. PubMed ID: 23552974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.
    Jennings FW; Atouguia JM; Murray M
    Acta Trop; 1996 Oct; 62(2):83-9. PubMed ID: 8988309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genital lesions in male red fronted gazelles (Gazella rufifrons) experimentally infected with Trypanosoma brucei and the effect of melarsamine hydrochloride (Cymelarsan®) and diminazene aceturate (Berenil®) in its treatment.
    Mbaya AW; Nwosu CO; Kumshe HA
    Theriogenology; 2011 Sep; 76(4):721-8. PubMed ID: 21601916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glutathione in the biliary excretion of the arsenical drugs trimelarsan and melarsoprol.
    Gregus Z; Gyurasics A
    Biochem Pharmacol; 2000 Jun; 59(11):1375-85. PubMed ID: 10751546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
    Carter NS; Fairlamb AH
    Nature; 1993 Jan; 361(6408):173-6. PubMed ID: 8421523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei.
    Fairlamb AH; Smith K; Hunter KJ
    Mol Biochem Parasitol; 1992 Jul; 53(1-2):223-31. PubMed ID: 1501642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.